Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN

Blood

Volumn 95, Issue 9, 2000, Pages 2937-2942

  Scarisbrick, Julia J ^a   Woolford, Alison J ^a   Russell Jones, Robin ^a   Whittaker, Sean J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; DNA DETERMINATION; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MYCOSIS FUNGOIDES; POINT MUTATION; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

EID: 0034193127     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.9.2937.009k15_2937_2942     Document Type: Article

References (37)

1. Thangavelu M, Finn WG, Yelavarthi KK, et al. Recurring structural chromosomal abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sezary syndrome. Blood 1997; 89:3371.
2. Karenko L, Hyytinen E, Sarna S, Ranki A. Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol. 1997;108:22.
3. Limon J. Nedoszytko B, Brozek I, et al. Chromosome aberrations, spontaneous SCE and growth kinetics in PHA-stimulated lymphocytes in 5 cases of Sezary syndrome. Cancer Genet Cytogenet. 1995;83:75.
4. Karenko L, Kahkonen M, Hyytinen E, Lindlof M, Ranki A. Notable losses at specific regions of chromosome 10q and 13q in the Sezary syndrome detected by comparative genomic hybridization. J Invest Dermatol. 1999;112:392.
5. Cerroni L, Volkenandt M, Reiger E, Soyer P, Kerl H. Bcl-2 protein expression and correlation with the inter-chromosomal 14;18 translocation in cutaneous lymphoma and pseudolymphoma. J Invest Dermatol. 1994;102:231.
6. DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30 + lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood. 1996;87:3437.
7. McGregor JM, Dublin EA. Levison DA, MacDonald DM, Smith NP, Whittaker S. p53 Immunoreactivity is uncommon in primary cutaneous lymphoma. Br J Dermatol. 1995;132:353.
8. Lauritzen AF, Vejlsgaard GL, Hou-Jensen K, Ralfkier E. p53 protein expression in cutaneous T-cell lymphomas. Br J Dermatol. 1995;133:32.
9. McGregor JM, Crook T, Fraser-Andrews EA, Rozycka M, Crossland S, Whittaker SJ. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol. 1999;112:317
10. Marks DI, Vonderheid EC, Kurz BW, et al. Analysis of p53 and mdm-2 expression in 18 patients with Sezary syndrome. Br J Haematol 92:890, 1996.
11. Park JK, Le Beau MM, Shows TB, Rowley JD, Diaz MO. A complex genetic rearrangement in a t(10;14)(q24;q11) associated with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 1992;4:32.
12. Speaks SL, Sanger WG, Masih AS, Harrington DS, Hess M, Armitage JO. Recurrent abnormalities of chromosomal bands 10q23-25 in non-Hodgkin's lymphoma. Genes Chromosomes Cancer. 1993;5:239.
13. Siebert R, Gesk S, Harder S, et al. Deletions in the long arm of chromosome 10 in lymphomas with t(14:18): a pathogenetic role of the tumour suppressor genes PTEN/MMAC1 and MXI1? [letter] Blood. 1998;92:4487.
14. Liaw D, Marsh DJ, Li J, et al. Germline mutations ol the PTEN gene in Cowden's disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997;16:64.
15. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase mutated in human brain, breast and prostate cancer. Science. 1997; 275:1943.
16. Nakahara Y, Nagai H, Kinoshita T, Uchida T, Hatano S, Saito H. Mutational analysis of the PTEN gene in non-Hodgkin's lymphoma. Leukaemia. 1998;12:1277.
17. Gronbaek K, Zeuthen J, Ralfkiaer E, Hou-Jensen K. Alterations of PTEN gene in lymphoid malignancies [letter] Blood. 1998;91:4388.
18. Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M. PTEN gene alterations in lymphoid neoplasms. Blood. 1998;92:3410.
19. Suzuki A, Pompa JL, Stambolic V, et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumour suppressor gene in mice. Curr Biol. 1998;8:1169.
20. Wechsler DS, Shelly CA, Dang CV. Genomic organization of human MXI1, a putative tumor suppressor gene. Genomics. 1996;32:466.
21. Mollenhauer J, Wiemann S, Scheurlen W, et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1. Nat Genet. 1997; 15:356.
22. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812.
23. Wooster R, Cleton-Jansen A-M, Collins N, et al. Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet. 1994;6:152.
24. Peng H, Chen G, Du M, Singh N, Isaacson PG, Pan L. Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue. Am J Pathol. 1996;148: 643.
25. Gartenhaus R, Johns MM III, Wang P, Rai K, Sidransky D. Mutator phenotype in a subset of chronic lymphocytic leukemia. Blood. 1996;87:38.
26. Gamberi B, Gaidano G, Parsa N, et al. Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas. Blood. 1997;89:975.
27. Hayami Y, Komatsu H, Iida S, et al. Microsatellite instability as a potential marker for poor prognosis in adult T cell leukemia/lymphoma. Leuk Lymphoma. 1999;32:345.
28. Whittaker SJ, Smith NP, Russell-Jones R, Luzzatlo L. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome. Cancer. 1991;68:1572.
29. Whittaker SJ. T-cell receptor gene analysis in cutaneous T-cell lymphomas. Clin Exp Dermatol. 1997;21:81.
30. Gyapay G, Morissette J, Vignal A, et al. The 1993-4 Genethon Human Genetic Linkage Map. Nat Genet. 1994;7:246.
31. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58: 5248.
32. Cairns P, Okami K, Halachmi S, et al. Frequent Inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 1997;57:4997.
33. Cairns P, Polascik TJ, Eby Y, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet. 1995;11:210.
34. Russell-Jones R, Whittaker SJ. TCR gene analysis in the diagnosis of Sézary syndrome. J Am Acad Dermatol. 1999;41:254.
35. Cappellen D, Medina S, Chopin D, Thiery JP, Radvanyi F. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas. Oncogens. 1997;14: 3059.
36. Tsukamoto K, Noriko I, Yoshimoto M, et al. Allelic loss on chromosome 1 p is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer. 1998;82: 317.
37. Saretzki G, Hoffmann U, Rohlke P, et al. Identification of allelic losses in benign, borderline, and invasive epilhelial ovarian tumors and correlation with clinical outcome. Cancer. 1997;80: 1241.